论文部分内容阅读
肝移植已经成为治疗肝癌的重要手段。选择合适的病人是一个重要的问题,国际通行的是米兰标准,我国一般公认的适应证主要包括:合并有肝硬变失代偿、不能接受肝切除治疗的小肝癌患者和肿瘤多发且波及左右两叶、肝功能严重损害、行切除术后肿瘤容易复发或出现肝功能衰竭者。血管侵犯,细胞分化程度等因素可以影响治疗的预后。围手术期辅助治疗(经皮肝动脉化学栓塞、经皮无水酒精瘤内注射、射频消融,氩氦刀治疗)对于提高肝移植的疗效有一定的意义。
Liver transplantation has become an important means of treatment of liver cancer. Choose the right patient is an important issue, the international standard is Milan, the general accepted indications in our country include: small liver cancer patients with decompensated liver cirrhosis can not accept hepatectomy and multiple and spread around the tumor Two leaves, severe damage to liver function, resection of the tumor prone to recurrence or liver failure. Vascular invasion, the degree of cell differentiation and other factors can affect the prognosis of treatment. Perioperative adjuvant therapy (percutaneous transhepatic arterial chemoembolization, percutaneous ethanol injection, radiofrequency ablation, argon-helium knife treatment) to improve the efficacy of liver transplantation is of some significance.